Skip to main content
SpringerLink
Log in

Setting Quality Standards for Stem Cell Banking, Research and Translation: The International Stem Cell Banking Initiative

  • Chapter
  • First Online:
Stem Cell Banking

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

Abstract

Delivery of human stem cells for research, clinical translation, and commercialization ideally requires stem cell resources developed and maintained according to internationally recognized standards. For example, human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells should conform to international ethical principles imparted by leading bodies such as the International Society of Stem Cell Research (ISSCR; www.isscr.org), International Stem Cell Forum (ISCF; www.stem-cell-forum.net), and U.S. National Academy of Sciences (USNAS; www.nasonline.org), and be quality-controlled based on principles of best-practice for manufacture, culture, characterization, storage, distribution, and translation. The International Stem Cell Banking Initiative (ISCBI) has taken the lead in defining such principles so as to standardize current and future practices that are essential to good scientific practice and clinical use through regulatory and public approval. This chapter considers the importance of standardizing stem cell banking and the central role of ISCBI as a major proponent of coordinated hES and iPS cell banking.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. ISCBI. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev. 2009;5:301–14.

    Article  Google Scholar 

  2. Crook JM, Hei D, Stacey G. The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on. In Vitro Cell Dev Biol Anim. 2010;46:169–72.

    Article  PubMed  Google Scholar 

  3. Crook JM, Peura TT, Kravets L, Bosman AG, Buzzard JJ, Horne R, Hentze H, Dunn NR, Zweigerdt R, Chua F, Upshall A, Colman A. The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell. 2007;1:490–4.

    Article  CAS  Google Scholar 

  4. Querol S, Gomez SG, Pagliuca A, Torrabadella M, Madrigal JA. Quality rather than quantity: the cord blood bank dilemma. Bone Marrow Transplant. 2010;45:970–8.

    Article  CAS  PubMed  Google Scholar 

  5. Luong MX, Auerbach J, Crook JM, Daheron L, Hei D, Lomax G, et al. A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell. 2011;8:357–9.

    Article  CAS  PubMed  Google Scholar 

  6. Laurie G, Bruce A, Lyall C. The roles of values and interests in the governance of the life sciences: learning lessons from the ‘Ethics+’ approach of UK Biobank. In: Lyall C, Papaioannou T, Smith J, editors. The limits to governance: the challenge of policy-making for the new life sciences. Aldershot: Ashgate; 2009. p. 51–77.

    Google Scholar 

  7. Human Tissue Act. 2004. http://www.legislation.gov.uk/ukpga/2004/30/contents

  8. EU tissue and cells directive. 2004. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:102:0048:0058:en:PDF

  9. Isasi R, Knoppers BM. From banking to international governance: fostering innovation in stem cell research. Stem Cells Int. 2011;2011:498132.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Chatterjee R. Cell biology. Cases of mistaken identity. Science. 2007;315:928–31.

    Article  CAS  PubMed  Google Scholar 

  11. ATCC. Cell line misidentification: the beginning of the end. Nat Rev Cancer. 2010;10:441–8.

    Article  Google Scholar 

  12. Buta C, David R, Dressel R, Emgard M, Fuchs C, Gross U, et al. Reconsidering pluripotency tests: do we still need teratoma assays? Stem Cell Res. 2013;11:552–62.

    Article  PubMed  Google Scholar 

  13. OECD. Organisation for Economic Co-operation and Development Directive 2004/10/EC, principles of good laboratory practice (GLP). J Eur Union. 2004;50:44–59.

    Google Scholar 

  14. USFDA. Code of Federal Regulations (CFR) 21, Part 58: good laboratory practice for nonclinical laboratory studies. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=58

  15. Coecke S, Balls M, Bowe G, Davis J, Gstraunthaler G, Hartung T, et al. Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice. Altern Lab Anim. 2005;33:261–87.

    CAS  PubMed  Google Scholar 

  16. OECD. Organisation for Economic Co-operation and Development Directive 2004/23/EC, Standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. J Eur Union. 2004;2102:48–58.

    Google Scholar 

  17. OECD. Organisation for Economic Co-operation and Development Directive 2004/17/EC, technical requirements for the donation, procurement and testing of human tissues and cells. J Eur Union. 2006;38:40–52.

    Google Scholar 

  18. Hug K. Banks, repositories and registries of stem cell lines in Europe: regulatory and ethical aspects. Stem Cell Rev. 2009;5:18–35.

    Article  PubMed  Google Scholar 

  19. Liddell K, Wallace S. Emerging regulatory issues for human stem cell medicine. Genomics Soc Policy. 2005;1:54–73.

    Article  Google Scholar 

  20. Stacey G, Crook JM, Hei D, Ludwig T. Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells? Cell Stem Cell. 2013;13:385–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ARC Centre of Excellence for Electromaterials Science (ACES), Intelligent Polymer Research Institute, AIIM Facility, University of Wollongong, Wollongong, NSW, 2522, Australia

    Jeremy M. Crook

  2. Australian Institute of Innovative Materials, University of Wollongong, Wollongong, NSW, 2522, Australia

    Jeremy M. Crook

  3. Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, 2522, Australia

    Jeremy M. Crook

  4. Department of Surgery—St. Vincent’s Hospital, The University of Melbourne, Melbourne, VIC, Australia

    Jeremy M. Crook

  5. UK Stem Cell Bank, National Institute for Biological Standards and Control, South Mimms, Blanche Lane, Potters Bar, EN6 3QG, Hertfordshire, UK

    Glyn N. Stacey

Authors
  1. Jeremy M. Crook
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Glyn N. Stacey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeremy M. Crook .

Editor information

Editors and Affiliations

  1. Division of Women's Health, King's College London School of Medicine, United Kingdom

    Dusko Ilic

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Crook, J.M., Stacey, G.N. (2014). Setting Quality Standards for Stem Cell Banking, Research and Translation: The International Stem Cell Banking Initiative. In: Ilic, D. (eds) Stem Cell Banking. Stem Cell Biology and Regenerative Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0585-0_1

Download citation

Publish with us

Policies and ethics

Search

Navigation